Brian I. Knapp

1.0k total citations
35 papers, 683 citations indexed

About

Brian I. Knapp is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Behavioral Neuroscience. According to data from OpenAlex, Brian I. Knapp has authored 35 papers receiving a total of 683 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 27 papers in Cellular and Molecular Neuroscience and 2 papers in Behavioral Neuroscience. Recurrent topics in Brian I. Knapp's work include Neuropeptides and Animal Physiology (26 papers), Receptor Mechanisms and Signaling (22 papers) and Pharmacological Receptor Mechanisms and Effects (21 papers). Brian I. Knapp is often cited by papers focused on Neuropeptides and Animal Physiology (26 papers), Receptor Mechanisms and Signaling (22 papers) and Pharmacological Receptor Mechanisms and Effects (21 papers). Brian I. Knapp collaborates with scholars based in United States, Italy and Ireland. Brian I. Knapp's co-authors include Jean M. Bidlack, John L. Neumeyer, Xuemei Peng, Ao Zhang, Wennan Xiong, Mark P. Wentland, James E. Hilbert, Michael Decker, Severo Salvadori and Lawrence H. Lazarus and has published in prestigious journals such as Biochemistry, Biological Psychiatry and Pain.

In The Last Decade

Brian I. Knapp

34 papers receiving 675 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brian I. Knapp United States 16 433 402 103 81 75 35 683
Nicole Kennedy United States 9 435 1.0× 388 1.0× 122 1.2× 48 0.6× 102 1.4× 19 664
János Marton Hungary 14 208 0.5× 199 0.5× 117 1.1× 47 0.6× 65 0.9× 37 443
Nicolette C. Ross United States 12 603 1.4× 473 1.2× 63 0.6× 61 0.8× 145 1.9× 12 778
Bernard Levet‐Trafit Switzerland 9 379 0.9× 273 0.7× 142 1.4× 87 1.1× 115 1.5× 9 727
Philip Pitis United States 7 571 1.3× 538 1.3× 88 0.9× 38 0.5× 127 1.7× 7 774
Shigeru Ohta Japan 9 133 0.3× 257 0.6× 85 0.8× 41 0.5× 59 0.8× 10 524
Michael Koblish United States 11 642 1.5× 642 1.6× 52 0.5× 141 1.7× 210 2.8× 13 929
Celia A. Whitesitt United States 13 359 0.8× 259 0.6× 128 1.2× 76 0.9× 55 0.7× 27 560
Juan Fernando Padín Spain 15 276 0.6× 193 0.5× 51 0.5× 51 0.6× 83 1.1× 43 554
Michio Terai United Kingdom 11 362 0.8× 240 0.6× 75 0.7× 69 0.9× 99 1.3× 24 613

Countries citing papers authored by Brian I. Knapp

Since Specialization
Citations

This map shows the geographic impact of Brian I. Knapp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian I. Knapp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian I. Knapp more than expected).

Fields of papers citing papers by Brian I. Knapp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian I. Knapp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian I. Knapp. The network helps show where Brian I. Knapp may publish in the future.

Co-authorship network of co-authors of Brian I. Knapp

This figure shows the co-authorship network connecting the top 25 collaborators of Brian I. Knapp. A scholar is included among the top collaborators of Brian I. Knapp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian I. Knapp. Brian I. Knapp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Knapp, Brian I., et al.. (2020). Unique Pharmacological Properties of the Kappa Opioid Receptor Signaling Through Gαz as Shown with Bioluminescence Resonance Energy Transfer. Molecular Pharmacology. 98(4). 462–474. 7 indexed citations
4.
Bidlack, Jean M., Brian I. Knapp, Daniel R. Deaver, et al.. (2018). In Vitro Pharmacological Characterization of Buprenorphine, Samidorphan, and Combinations Being Developed as an Adjunctive Treatment of Major Depressive Disorder. Journal of Pharmacology and Experimental Therapeutics. 367(2). 267–281. 50 indexed citations
5.
Callaghan, Charlotte K., Reginald L. Dean, Brian I. Knapp, et al.. (2017). Antidepressant-like effects of 3-carboxamido seco-nalmefene (3CS-nalmefene), a novel opioid receptor modulator, in a rat IFN-α-induced depression model. Brain Behavior and Immunity. 67. 152–162. 11 indexed citations
6.
Sromek, Anna W., et al.. (2014). Preliminary Pharmacological Evaluation of Enantiomeric Morphinans. ACS Chemical Neuroscience. 5(2). 93–99. 17 indexed citations
7.
Knapp, Brian I., M. Dhanasekaran, Denise Giuvelis, et al.. (2014). Can Amphipathic Helices Influence the CNS Antinociceptive Activity of Glycopeptides Related to β-Endorphin?. Journal of Medicinal Chemistry. 57(6). 2237–2246. 12 indexed citations
8.
Sromek, Anna W., Wei Li, Elena H. Chartoff, et al.. (2013). Synthesis and Pharmacological Evaluation of Aminothiazolomorphinans at the Mu and Kappa Opioid Receptors. Journal of Medicinal Chemistry. 56(21). 8872–8878. 17 indexed citations
9.
Yeomans, Larisa, M. Dhanasekaran, John J. Lowery, et al.. (2011). Phosphorylation of Enkephalins: NMR and CD Studies in Aqueous and Membrane‐Mimicking Environments. Chemical Biology & Drug Design. 78(5). 749–756. 4 indexed citations
10.
Hough, Lindsay B., Julia W. Nalwalk, Jun Yang, et al.. (2011). Brain P450 epoxygenase activity is required for the antinociceptive effects of improgan, a nonopioid analgesic. Pain. 152(4). 878–887. 12 indexed citations
11.
Balboni, Gianfranco, Severo Salvadori, Ewa D. Marczak, et al.. (2010). Opioid bifunctional ligands from morphine and the opioid pharmacophore Dmt-Tic. European Journal of Medicinal Chemistry. 46(2). 799–803. 10 indexed citations
12.
Knapp, Brian I., et al.. (2009). Glycosyl-Enkephalins: Synthesis and Binding at the Mu, Delta & Kappa Opioid Receptors. Antinociception in Mice. Advances in experimental medicine and biology. 611. 495–496. 3 indexed citations
13.
Knapp, Brian I., et al.. (2008). Synthesis and pharmacological evaluation of hydrophobic esters and ethers of butorphanol at opioid receptors. Bioorganic & Medicinal Chemistry Letters. 18(16). 4474–4476. 8 indexed citations
14.
Peng, Xuemei, Brian I. Knapp, Jean M. Bidlack, & John L. Neumeyer. (2007). High-affinity carbamate analogues of morphinan at opioid receptors. Bioorganic & Medicinal Chemistry Letters. 17(6). 1508–1511. 10 indexed citations
15.
Peng, Xuemei, Brian I. Knapp, Jean M. Bidlack, & John L. Neumeyer. (2007). In-vitro investigation of oxazol and urea analogues of morphinan at opioid receptors. Bioorganic & Medicinal Chemistry. 15(12). 4106–4112. 9 indexed citations
16.
Lowery, John J., Larisa Yeomans, Peg Davis, et al.. (2007). Glycosylation Improves the Central Effects of DAMGO. Chemical Biology & Drug Design. 69(1). 41–47. 36 indexed citations
17.
Wentland, Mark P., et al.. (2005). Synthesis and opioid receptor binding properties of a highly potent 4-hydroxy analogue of naltrexone. Bioorganic & Medicinal Chemistry Letters. 15(8). 2107–2110. 36 indexed citations
18.
Zhang, Ao, Wennan Xiong, Jean M. Bidlack, et al.. (2003). 10-Ketomorphinan and 3-Substituted-3-desoxymorphinan Analogues as Mixed κ and μ Opioid Ligands:  Synthesis and Biological Evaluation of Their Binding Affinity at Opioid Receptors. Journal of Medicinal Chemistry. 47(1). 165–174. 37 indexed citations
19.
Neumeyer, John L., Ao Zhang, Wennan Xiong, et al.. (2003). Design and Synthesis of Novel Dimeric Morphinan Ligands for κ and μ Opioid Receptors. Journal of Medicinal Chemistry. 46(24). 5162–5170. 71 indexed citations
20.
Knapp, Brian I.. (1979). ELEMENTS OF GEOGRAPHICAL HYDROLOGY. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicole Kennedy Breakdown of academic impact, for papers by János Marton Breakdown of academic impact, for papers by Nicolette C. Ross Breakdown of academic impact, for papers by Bernard Levet‐Trafit Breakdown of academic impact, for papers by Philip Pitis Breakdown of academic impact, for papers by Shigeru Ohta Breakdown of academic impact, for papers by Michael Koblish Breakdown of academic impact, for papers by Celia A. Whitesitt Breakdown of academic impact, for papers by Juan Fernando Padín Breakdown of academic impact, for papers by Michio Terai
Rankless by CCL
2026